← Leaderboards
Yanxin Pei
Children'S Research Institute
$4,377,644
Attributed
$4,377,644
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $921.4K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,377,644 · 4
By mechanism
R01$3,436,218 · 2
R21$941,426 · 2
Top collaborators
No co-investigators on record.
Most similar at Children'S Research Institute
Same institution · by research overlap
- Roger Packer$5,643,404
- Dana Ashley Hill$5,205,889
- Dietrich A Stephan$13,570,976
- Adan A Aguirre$2,454,238
- Thomas Forbes$62,659
Others in their field
Top investigators on “Tumor Growth”
- David Heimbrook · Leidos Biomedical Research, Inc.$146,387,105
- Israel David Goldman · Yeshiva University$49,502,983
- Candace S Johnson · University Of Pittsburgh At Pittsburgh$44,839,363
- C Kent Osborne · Baylor College Of Medicine$40,237,256
- Alan F Horwitz · University Of Virginia Charlottesville$39,846,480
- Douglas Yee · University Of Minnesota$38,475,268
Research focus
Tumor GrowthCellsTumorMalignant Neoplasm Of BrainMolecularMedulloblastomaEffective TherapySurvival RateRelapseGrowthPreventChildhood Malignant Brain TumorIn VivoTherapy ResistantExhibitsResistanceChemotherapyRadiationMouse ModelNeoplastic CellShh GeneHigh Dose ChemotherapySubgroupPediatric Neoplasm
Grant awards (13)
Oncogenic mechanisms underlying GLI2-amplified medulloblastoma$372,698
R01 · FY2025 · NS · contact PI
Oncogenic mechanisms underlying GLI2-amplified medulloblastoma$507,610
R01 · FY2024 · NS · contact PI
Oncogenic mechanisms underlying GLI2-amplified medulloblastoma$523,308
R01 · FY2023 · NS · contact PI
The role of Olig2 in the tumorigenesis, progression and metastasis in MYC-amplified medulloblastoma$398,055
R01 · FY2023 · CA · contact PI
The role of Olig2 in the tumorigenesis, progression and metastasis in MYC-amplified medulloblastoma$398,055
R01 · FY2022 · CA · contact PI
The role of Olig2 in the tumorigenesis, progression and metastasis in MYC-amplified medulloblastoma$406,178
R01 · FY2021 · CA · contact PI
The role of Olig2 in the tumorigenesis, progression and metastasis in MYC-amplified medulloblastoma$410,439
R01 · FY2020 · CA · contact PI
The role of Olig2 in the tumorigenesis, progression and metastasis in MYC-amplified medulloblastoma$419,875
R01 · FY2019 · CA · contact PI
Tumor-initiating and propagating cells in MYC-driven medulloblastoma$262,500
R21 · FY2018 · NS · contact PI
Tumor-initiating and propagating cells in MYC-driven medulloblastoma$218,750
R21 · FY2017 · NS · contact PI
(PQ6) Molecular Mechanisms of Dormancy in MYC-Driven Medulloblastoma$181,439
R21 · FY2014 · CA · contact PI
(PQ6) Molecular Mechanisms of Dormancy in MYC-Driven Medulloblastoma$24,262
R21 · FY2014 · CA · contact PI
(PQ6) Molecular Mechanisms of Dormancy in MYC-Driven Medulloblastoma$254,475
R21 · FY2013 · CA · contact PI